Target

IGF-1R

Aliases
IGF-1

62 products, 69 indications

Indications
NSCLC (7 products)
Metastatic Castration-Resistant Prostate Cancer (4 products)
Locally advanced squamous cell carcinoma of the head and neck (3 products)
high grade serous ovarian carcinoma (3 products)
Ovarian Cancer (3 products)
extensive-stage SCLC (2 products)
biliary tract cancer (2 products)
oesophageal squamous cell carcinoma (2 products)
mucosal melanoma (2 products)
Non-Small Cell Lung Cancer (2 products)
stage III non-small cell lung cancer (2 products)
Non-small Cell Lung Cancer, Gastric Carcinoma, Gastroesophageal Junction Carcinoma, Classical Hodgkin Lymphoma, Diffuse Large B-cell Lymphoma, Peripheral T-cell Lymphoma, Cutaneous Melanoma, Head and Neck Squamous Cell Carcinoma, Bladder Cancer, Ovarian Cancer, Triple Negative Breast Cancer, Cervical Cancer (2 products)
unresectable stage IIIA/IIIB NSCLC (2 products)
metastatic non-small cell lung cancer (2 products)
stage IV locoregionally advanced nasopharyngeal carcinoma (1 products)
Advanced high-grade ovarian cancer (1 products)
EGFRm+ NSCLC with CNS metastasis (1 products)
Rectal squamous cell carcinoma (1 products)
Advanced extrahepatic cholangiocarcinoma and gallbladder cancer (1 products)
EGFR-negative refractory advanced NSCLC (1 products)
advanced urothelial carcinoma (1 products)
resectable stage II - III non-small cell lung cancer (1 products)
advanced squamous non-small-cell lung cancer (1 products)
cervical cancer (1 products)
Hypopharyngeal squamous cell carcinoma (1 products)
Locally advanced oral squamous cell carcinoma (LA-OSCC) (1 products)
stage IV NSCLC (1 products)
recurrent or metastatic head and neck squamous cell carcinoma (1 products)
fallopian tube cancer (1 products)
platinum-resistant/refractory epithelial ovarian cancer (1 products)
High-risk non-muscle invasive bladder cancer (1 products)
Prostate cancer (1 products)
recurrent high-grade epithelial ovarian, fallopian tube, or primary peritoneal cancer (1 products)
Unresectable stage III non-small cell lung cancer (1 products)
ROS1-rearranged NSCLC (1 products)
unresectable stage 3 NSCLC (1 products)
Advanced Epithelial Ovarian Cancer (1 products)
Advanced gastric adenocarcinoma (1 products)
Inoperable locally advanced squamous cell carcinoma of the head and neck (1 products)
Squamous cell carcinoma of the head and neck (1 products)
Early stage epithelial ovarian cancer (1 products)
locally advanced laryngeal carcinoma (1 products)
HNSCC (1 products)
Locally advanced non-small cell lung cancer (1 products)
advanced non-squamous NSCLC (1 products)
unresectable locally advanced head and neck squamous cell carcinoma (1 products)
ampullary carcinoma (1 products)
Metastatic colorectal cancer (1 products)
Brain Metastases from Metastatic Non-Seminomatous Germ Cell Tumors (NSGCT) (1 products)
Stage IIIB/IIIC NSGCTs (1 products)
Stage I MOGCTs (IA dysgerminoma and IAG1 immature teratoma) (1 products)
Stage I MOGCTs (IC yolk sac tumors and mixed IC2 with yolk sac tumors) (1 products)
High-grade serous ovarian cancer (HGSOC) (1 products)
Stage III unresectable NSCLC with EGFR mutations (1 products)
EGFR ex20ins-mutant NSCLC (1 products)
Advanced acral and mucosal melanoma (1 products)
Advanced melanoma (1 products)
locally advanced/metastatic cancers (1 products)
small cell lung cancer (1 products)
Limited Disease Small Cell Lung Cancer (1 products)
anaplastic thyroid cancer (1 products)
non-small lung cancer (1 products)
metastatic melanoma (1 products)
Melanoma and Merkel Cell Carcinoma (1 products)
recurrent ovarian, fallopian tube and primary peritoneal cancer (1 products)
resectable stage IIIA NSCLC (1 products)
Metastatic Neuroendocrine Prostate Cancer (1 products)
Relapsed refractory melanoma (1 products)
glioblastoma (1 products)
Loading...

2 drugs

4 abstracts

Abstract
Association of elevated ctDNA burden following one cycle of chemotherapy with inferior outcomes for patients with metastatic Ewing sarcoma: A report from the Children’s Oncology Group (COG).
Org: Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Children's Oncology Group Statistics and Data Center, University of Florida, Broad Institute of MIT and Harvard, The University of Texas MD Anderson Cancer Center, Stem Cell Transplantation Rsch, Houston, TX, Memorial Sloan Kettering Cancer Center,
Abstract
Metformin with neoadjuvant chemotherapy in localized triple negative and HER2neu-positive breast cancer: A prospective phase 2 open label randomised controlled trial (McBETH).
Org: All India Institute of Medical Sciences (AIIMS), Rishikesh, India, Dr. Brairch, NCI AIIMS, National Cancer Institute-All India Institute of Medical Science (AIIMS),
Abstract
A phase II study of concurrent WOKVAC vaccination with neoadjuvant chemotherapy and HER2-targeted monoclonal antibody therapy.
Org: University of Washington and Fred Hutchinson Cancer Research Centre, Cancer Vaccine Institute, University of Washington Medical Center,
Abstract
Energetics and Lifestyle in Inherited Syndromes (ELLIES Project): Feasibility of remote specimen collection for biomarker analysis.
Org: The University of Kansas Medical Center, University of Kansas Cancer Center, Kansas City, KS, University of Kansas Medical Center, Department of Biostatistics & Data Science,